No Data
No Data
Preview: Os Therapies Incorporated Set To IPO Tomorrow
OS Therapies Incorporated (NYSE:OSTX) IPO will take place June, 21 on the NYSE exchange under the ticker OSTX.The company is offering shares at an expected price of $4.00 per share with an insider lo
OS Therapies Announces Positive Clinical Update From Ongoing Phase 2b Clinical Trial in Resected, Recurrent Osteosarcoma
OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage oncology-focused immunotherapy company developing cancer vaccines and antibody drug conjugate (ADC) therapeutic candidates, today announced a positive clinical update for AOST-2121 (NCT04974008), its ongoing Phase 2b clinical trial of its immunotherapy OST-HER2 (OST31-154) in patients with resected, recurrent osteosarcoma.
Oncology Drug Developer OS Therapies Refiles for $8M IPO
OS Therapies (OSTX) has refiled to raise $8M through a proposed initial public offering.
OS Therapies Incorporated | 10-Q: Quarterly report
No Data